Patience David 4
4 · Accelerate Diagnostics, Inc · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Patience David
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-26+1,000→ 26,597 total - Sale
Common Stock
2024-02-26$0.96/sh−350$336→ 26,247 total - Exercise/Conversion
Employee Restricted Stock Units
2024-02-26−1,000→ 1,500 total→ Common Stock (1,000 underlying)
Holdings
- 760(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units ("RSUs"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting.
- [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.